Endoscopic versus open vein harvesting technique and 2-year saphenous vein graft patency: A subanalysis of the Newton-CABG CardioLink-5 randomized trial
Year: 2026
Type: article
Abstract: To view the AATS Annual Meeting Webcast,
Source: JTCVS Open
Institutions: Royal College of Surgeons in Ireland, St. Michael's Hospital, Unity Health Toronto, University of Toronto, University of British Columbia, SUNY Downstate Health Sciences University, University of Colorado Anschutz, University of Colorado Denver, Icahn School of Medicine at Mount Sinai, University of Oxford, Jacksonville Center for Clinical Research, Monash University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,431
Funders: American Heart Association, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, GlaxoSmithKline, Sanofi, Brigham and Women's Hospital, Alnylam Pharmaceuticals, Cleveland Clinic, AtriCure, CSL Behring, Boston Scientific Corporation, Ultragenyx Pharmaceutical, Amarin Corporation, Belvoir Media Group, Novo Nordisk, Assistance publique-Hôpitaux de Paris, Idorsia Pharmaceuticals, HLS Therapeutics, Esperion Therapeutics, National Institutes of Health, Amgen Canada, Science and Engineering Research Board, Duke Clinical Research Institute
OpenAlex ID: W7203664999
